Showing results (371-380 of 561) with videos related to

Sort By:
Pageof 57
Frontiers in Human Neuroscience|January 23, 2023
Increases in sensory noise predict attentional disruptions to audiovisual speech perceptionVictoria L Fisher, Cassandra L Dean, Claire S Nave, et al.
Molecular Ecology|October 12, 2013
Nitrogen deposition alters plant-fungal relationships: linking belowground dynamics to aboveground vegetation changeSarah L Dean, Emily C Farrer, D Lee Taylor, et al.
Poultry Science|December 12, 2018
Feeding high-oleic peanuts to layer hens enhances egg yolk color and oleic fatty acid content in shell eggsOndulla T Toomer, Amanda M Hulse-Kemp, Lisa L Dean, et al.
American Journal of Obstetrics and Gynecology|November 1, 1985
Cytochrome P-450 activity in human leiomyoma and normal myometriumT I Senler, G E Hofmann, J S Sanfilippo, et al.
The Journal of Antibiotics|December 1, 1985
Catacandins, novel anticandidal antibiotics of bacterial originE Meyers, R Cooper, L Dean, et al.
American Journal of Physiology. Cell Physiology|February 6, 2009
Fibrinogen-induced endothelin-1 production from endothelial cellsUtpal Sen, Neetu Tyagi, Phani K Patibandla, et al.
International Journal of Environmental Research and Public Health|April 13, 2023
Evaluating a Telephone and Home Blood Pressure Monitoring Intervention to Improve Blood Pressure Control and Self-Care Behaviors in Adults with Low-Socioeconomic StatusKomlanvi S Avegno, Kristina B Roberson, Elijah O Onsomu, et al.
Cell Cycle (Georgetown, Tex.)|October 16, 2010
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic responseAdam Ertel, Jeffry L Dean, Hallgeir Rui, et al.
Regulatory Toxicology and Pharmacology : RTP|February 23, 2019
A case study on the application of an expert-driven read-across approach in support of quantitative risk assessment of p,p'-dichlorodiphenyldichloroethaneLucina E Lizarraga, Jeffry L Dean, J Phillip Kaiser, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 22, 2003
Vivitrex, an injectable, extended-release formulation of naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for 1 month in ratsRaymond T Bartus, Dwaine F Emerich, Joyce Hotz, et al.
Pageof 57